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ABSTRACT 
Objective: To evaluate the maternal and neonatal out-
comes in women diagnosed as gestational diabetes mel-
litus (GDM) in different periods of pregnancy. 
Materials and Methods: This descriptive observational 
study was carried out from 1st January 2007 to 31th De-
cember 2007 in the department of Obstetrics and Gyne-
cology of a 1300 bedded tertiary care hospital "Bahawal 
Victoria Hospital" in Bahawalpur, Pakistan. Seventy six 
pregnant  women  met  the  inclusion  criteria  of  diabetes 
diagnosed  on  the  basis  of  the  Oral  glucose  tolerance 
test  (OGTT)  according  to  the  National  Diabetic  Data 
Group. The study subjects were divided on the basis of 
gestational age at the first time diagnosis of GDM in the 
current pregnancy into group A (gestational age 13-23 
weeks),  group  B  (24-30  weeks)  and  group  C  (31-36 
weeks). 
Results: Out of total study subjects, 19 (25%) were di-
agnosed  as  GDM  between  13-23  weeks  of  gestation 
(early-onset), 25 (32.9%) between 24-30 weeks while 32 
(42.1%)  diagnosed  in  the  gestational  age  of  31-35 
weeks  (late-onset).  Pregnancy-induced  hypertension  5 
(26.3%),  polyhydramnios  5  (26.3%)  and  insulin  treat-
ment 13 (68.4%) were higher in women with earlier GDM 
diagnosis (p<0.05). APGAR score at 5-min below seven 
was  seen  in  3  (15.8%),  large  for  gestational  age  in  5 
(26.3%), respiratory distress in 6 (31.5%) and pre-term 
delivery  in  5  (26.3%)  of  the  early  GDM  group.  These 
complications  were  seen  more  frequently  in  the  early 
group compared with late-onset GDM group (p<0.05).  
Conclusion: Earlier diagnosis of GDM was seem to be 
associated with less favorable newborn outcome. 
Key  Words:  Gestational  diabetes  mellitus;  maternal 
outcome; neonatal outcome; period of diagnosis 
ÖZET 
Amaç: Gebeliğin farklı dönemlerinde gestasyonel diabet 
tanısı alan kadınlarda anne ve bebek sonuçlarını değer-
lendirmek 
Gereç  ve  Yöntem:  Bu  tanımlayıcı  gözlemsel  çalışma 
Pakistan’daki 1300 yataklı “Bahawal Victoria Hastanesi” 
Kadın-Doğum Kliniğinde 1 Ocak-31 Aralık 2007 tarihleri 
arasında gerçekleştirildi. Oral glukoz tolerans testi sonu-
cuna göre Ulusal Diabet Veri Grubu kriterlerine uyan 76 
gebe kadın diabet tanısı aldı. Çalışma grubundaki hasta-
lar gestasyonel diabetin (GDM) ilk tanı anındaki gebelik 
dönemine  göre  Grup  A  (gebelik  haftası  13-23  arası), 
Grup B (24-30 haftalık gebelik) ve Grup C (31-36 haftalık 
gebelik) olarak alt gruplara ayrıldı. 
Bulgular: Toplam çalışma grubundan 19 (%25)’u erken 
başlangıçlı GDM (13-23 hafta), 25 (%32.9)’u 24-30 haf-
tada, 32 (%42.1)’i 31-36 haftada (geç başlangıçlı GDM 
idi. Erken başlangıçlı GDM’li grupta gebelik ilintili hiper-
tansiyon  5  (%26.3),  polihidramniyos  5  (%26.3),  insülin 
tedavisi 13 (%68.4)’ünde görüldü ve bu oranlar diğer dö-
nemlerdeki  hastalardan  daha  yüksekti  (p<0.05).  Erken 
GDM grubunda 5. dakikadaki APGAR puanı<7 üç has-
tada  (%15.8),  gebelik  yaşına  göre  büyük  bebek  5 
(%26.3)’inde, solunum sıkıntısı 6 (%31.5)’ında ve erken 
doğum 5 (%26.3) hastada görüldü. Bu komplikasyonlar 
erken GDM grubunda geç başlangıçlı GDM grubundan 
daha sık idi (p<0.05). 
Sonuç:  Erken  başlangıçlı  GDM  daha  olumsuz 
yenidoğan sonuçları ile birlikte gözükmektedir. 
Anahtar  kelimeler:  Gebelik  diyabeti,  anne  sonuçları, 
bebek sonuçları, tanı dönemi 
 
 
 
INTRODUCTION 
Gestational diabetes mellitus (GDM) is defined as 
"any degree of glucose intolerance with onset or 
first recognition during pregnancy". Its prevalence 
may range from 1 to 14% of all pregnancies be-
cause  of  diversity  of  population  studied  and  im-
plementation of different diagnostic tools
1. 
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Gestational  diabetes  mellitus  is  associated 
with maternal and fetal morbidity
2, because mater-
nal glucose level if rise during pregnancy cross the 
placenta  and  can  lead  to  fetal  hyperinsulinaemia 
which subsequently causes macrosomia and further 
increases  the  risk  of  shoulder  dystocia  and/or 
traumatic  delivery.  Moreover,  infant  of  diabetic 
mother has to face threats like hypoglycemia, res-
piratory distress and jaundice after delivery
3,4. Fur-
thermore, an elevated glucose during embryogene-
sis, in formerly undocumented type 2 diabetes mel-
litus predispose to congenital anomalies
5,6. 
It was mentioned in Fourth Workshop Confer-
ence on Gestational Diabetes Mellitus that screen-
ing in the early gestational period is only recom-
mended for those women who have high-risk char-
acteristics,  whereas those  at  low  risk could even 
pass over screening
7. However, Bartha in 2000, has 
reported a worse outcome for women with GDM 
diagnosed in the first 23 weeks of pregnancy
8. The 
typical  recommendation  is  to  perform  screening 
between 24–28 weeks of gestation despite the fact 
that 40% of women with GDM could be detected 
in the early weeks of pregnancy
9. 
We aimed to analyze the maternal and neona-
tal outcomes in the subjects diagnosed as GDM in 
different periods of pregnancy. 
MATERIALS AND METHODS 
This  descriptive  observational  study  was  carried 
out from 1st January 2007 to 31st December 2007 
(one year) in the department of Obstetrics and Gy-
necology  of  a  1300  bedded  tertiary  care  referral 
teaching hospital in Bahawalpur, Pakistan, the Ba-
hawal  Victoria  Hospital,  with  an  average  annual 
delivery rate of 2500.  
Inclusion Criteria 
It covered all singleton pregnant women attending 
the out patient department of obstetrics and gyne-
cology during the first trimester with one or more 
risk factors that is age >35 years, body mass index 
(BMI) >30, with risk factors in past history that is 
family history of diabetes mellitus in first degree 
relative, previous history of GDM, repeated mis-
carriages, unexplained still births and previous ma-
crosomic  or  congenitally  malformed  baby  were 
subjected  to  OGTT  and  regular  follow  up  espe-
cially for research purpose. 
Exclusion Criteria 
It  comprised  of  all  GDM  women  suffering  from 
some other disorders which directly or indirectly 
may affect the outcome of pregnancy that is asth-
ma, epilepsy, pre-pregnancy hypertension, thyroid 
dysfunction, anemia and heart problems. The preg-
nant women known to have pre-pregnancy diabetes 
mellitus or having OGTT positive in first twelve 
weeks  of  pregnancy  were  also  excluded  because 
pregnant women  diagnosed  to have GDM  in the 
first trimester are probably to have Type 2 DM
10. 
Subjects with poor glycemic control and follow up. 
Patients 
 Out of total (85) high risk cases who visited out 
patient department in first trimester, nine females 
were excluded from study because two had OGTT 
positive in first trimester two had poor glycemic 
control while five had OGTT positive subsequently 
but did not have regular follow up. Finally seventy 
six were enrolled as study subjects. The study sub-
jects were divided on the basis of gestational age at 
the  first  time  diagnosis  of  GDM  in  the  current 
pregnancy into three groups. Group A had gesta-
tional age 13-23 weeks, group B had >23-30weeks 
and group C had >30-36 weeks. 
Diagnosis of Gestational Diabetes Mellitus 
The  Oral  Glucose  Tolerance  Test  (OGTT)  was 
done  according  to  the  National  Diabetic  Data 
Group. After an over-night fasting of 8-14 hours 
and at least 3 days of unrestricted diet with unlim-
ited physical activity, venous plasma glucose con-
centrations  were  measured  in  fasting,  1  hour,  2 
hours and 3 hours samples after giving 100 gm of 
glucose in 250 ml of water orally. Patient was di-
agnosed as a case of GDM if two or more readings 
equaled  or  exceeded  the  levels  of  fasting  105 
mg/dL, 1 hour 190mg/dL, 2 hour 165 mg/dL, 3- 
Hour  145  mg/dL
11.  The  woman  with  negative 
OGTT in first visit was subjected to same test in 
subsequent visits.  
Management of Gestational Diabetes Mellitus 
 Dietary control was advised by a registered dieti-
cian for all women with GDM. Total calories per 
day were calculated according to 30-35 cal/kg of 
body weight and diet charts were given to them. 
Insulin treatment was initiated and adjusted in sub-
jects  with  failed  dietary  therapy  (>2  weeks)  to 
maintain the fasting whole blood glucose level be-
tween 70-100 mg/dl and two hours post parandial   
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less than 140 mg/dL according to American Diabe-
tes Association criteria
1. 
After adjusting insulin dosage, patients were dis-
charged with instructions to be followed regularly 
at antenatal clinic with glucose home monitoring 
(2 levels) and  to report immediately  in  case  any 
complication that is pregnancy induced hyperten-
sion,  preterm  labor,  premature  rupture  of  mem-
branes or decrease fetal movement.  
Obstetrical Management 
Baseline  investigations  carried  out  in  all  the  pa-
tients at the time of enrollment, that were hemo-
globin, blood group and Rh factor, complete ex-
amination  of  urine,  ultrasonography.  Liver  func-
tion, serum uric acid and renal functions were ad-
vised where indicated. At each antenatal visit, glu-
cose  home  monitoring  (fasting  and  2  hours  post 
prandial) record  was  checked,  maternal and  fetal 
well  being  were  assessed  and  if  there  was  any 
complication, the patient was readmitted and man-
aged accordingly. Ultrasonography was done early 
in gestation for fetal anomalies and was repeated if 
indicated. Elective caesarean section was reserved 
for those diabetics who had fetal macrosomia and 
emergency caesarean section was done for obstet-
rical indications. 
During  labor  and  prior  to  elective  caesarean 
section, euglycaemia was achieved by administer-
ing  intravenous  insulin via an  infusion pump to-
gether with intravenous dextrose at a rate of 10 g/h, 
using 10% solution. Maternal plasma glucose lev-
els  were  monitored  hourly  and  insulin  dose  ad-
justed to maintain the blood glucose concentration 
between  70-110  mg/dl
12. All  the  newborn babies 
were assessed by a pediatrician immediately after 
delivery. A structured proforma were used to col-
lect data after taking informed consent from sub-
jects. 
Outcome  measures  with  outcome  and 
operational definitions 
 Gestational  age  was  estimated  by  ultrasound bi-
ometry (via CRL measurements in the first trimes-
ter of pregnancy) in cases where there was more 
than 3 days difference from that obtained from the 
last menstrual period (LMP)
13. Pregnancy-induced 
hypertension  was  defined  as  a  blood  pressure 
>140/90mmHg  presenting  at  gestational  age  of 
>20  weeks  or  the  first  week  after  delivery,  con-
firmed as of 6 h later in a woman without a former 
diagnosis  of  hypertension,  or  previous  hyperten-
sion  worsening  during  pregnancy  and  requiring 
additional  treatment.  Perinatal  mortality  was  de-
fined as any fetal or neonatal death occurring from 
gestation of 22 weeks through the first 4 weeks af-
ter birth
14. Neonatal hypoglycemia was defined in 
accordance with Cornblath and Reisner’s criteria
15 
for capillary blood glucose, which take into con-
sideration both birth weight and prematurity. Neo-
natal  jaundice  was  defined  as  hyperbilirubinemia 
requiring treatment
16. All types of respiratory dis-
tress, including transient tachypnea, were consid-
ered. Preterm birth was defined as a birth before 37 
complete gestational weeks. Macrosomia was de-
fined as a birthweight of >4000 g. LGA newborns 
are defined as those with a birthweight of >90th 
percentile  for  the  corresponding  sex  and  gesta-
tional age
17. 
Informed  consent  was  obtained  from  all  partici-
pants. 
Statistical analysis 
The non-normally distributed continuous variables 
were expresed as median (range) and subjected to 
Kruskal-Wallis  analysis  of  variance.  Chi  square 
test was applied to categorical data. P-value <0.05 
was considered as significant. 
RESULTS 
During study period a total of 3550 deliveries were 
done and total cases diagnosed as GDM were 110 
(3.1%). Out of total (76) study subjects, 19 (25%) 
were diagnosed as GDM between 13-23weeks of 
gestation,  25(32.9%)  between  >23-30  while  32 
(42.1%) diagnosed in the gestational age of >30-35 
(p>0.05).  Maternal  median  age  was  higher  in 
group B 40 (36-47) than both of remaining groups 
but age range was wider in group C 38.7 (36-49). 
Multiparity  was  more  common  in  Group  C  18 
(56.3%) but not significant (P>0.05). 
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Table 1. Maternal features in different groups (N=76) 
Variables  Group A 
(n=19) 
Group B 
(n=25) 
Group C 
(n=32) 
p-value 
Age (yrs)  34 (30-39)  33 (29-40)  32.7(28-38)  *NS 
         0  3 (15.8)  3 (12)  6 (18.8) 
         1  6 (31.6)  10 (40)  8 (25) 
Parity 
       >1  10 (52.6)  12 (48)  18 (56.3) 
 
NS
† 
Height (cm)  156 (126-170)  154 (129-172)  151.2 (130-169)  NS* 
Weight (kg)  59 (43-69)  66 (52-75)  75.4 (58-86)  <0.05* 
BMI (kg/m
2)  23 (19-32)  28 (19-35)  32.1 (20-40)  <0.05* 
Hemoglobin (g/dl)  10.2 (8.3-13)  9.8 (8-12.9)  10.6 (8.9-12.4)  NS* 
Fasting  120 (88-130)  112 (62-145)  109 (72-138)  <0.05* 
1 hour  214 (99-336)  206 (89-324)  200.5 (111-321)  NS* 
2 hour  190 (109-320)  205 (96-326)  182 (94-280)  <0.05* 
Diagnostic 
OGTT 
(mg/dl) 
3 hour  144 (60-250)  150 (65-250)  157.5 (40-266)  <0.05* 
Results are expressed in median (range) or number (%), NS Not significant 
* Kruskal–Wallis ANOVA between periods. 
†χ
2-test  
 
Table 2. Maternal and fetal outcome in subjects groups (n=76) 
Variables  Group A 
(n=19) 
Group B 
(n=25) 
Group C 
(n=32) 
p-value
† 
Pregnancy induced hypertension  5 (26.3)  2 (8)  2 (6.3)  <0.05 
Recurrent Monilial Infection  2 (10.5)  2 (8)  1 (3.1)  NS 
Recurrent UTI  2 (10.5)  1 (4)  1 (3.1)  NS 
PROM  3 (15.8)  3 (12)  4 (12.5)  NS 
Ante partum hemorrhage  1(5.3)  1 (4)  1 (3.1)  NS 
Polyhydramnios  5 (26.3)  3 (12)  2 (6.3)  <0.05 
Insulin Treatment  13 (68.4)  11 (40)  8 (25)  <0.05 
Cesarean section  7 (36.8)  5 (20)  5 (15.6)  NS 
Spontaneous  7 (36.9)  11 (44)  15 (46.9) 
Instrumental  3 (15.8)  5 (20)  7 (21.9) 
Maternal 
Mode of delivery 
Breech  2 (10.5)  4 (16)  5 (15.6) 
NS 
5 minute APGAR score <7  3 (15.8)  0  1 (3.1)  <0.05 
Large for gestational age  5 (26.3)  3 (12)  3 (9.4)  <0.05 
Macrosomia  3 (15.8)  2 (8)  3 (9.4)  NS 
Shoulder dystocia  3 (15.8)  4 (16)  3 (9.37)  NS 
Perinatal mortality  2 (10.5)  3 (12)  2 (6.3)  NS 
Hypoglycemia  3 (15.8)  2 (8)  1 (3.1)  <0.05 
Hyperbilirubinemia  5 (26.3)  5 (25)  6 (18.9)  NS 
Respiratory distress  6 (31.5)  3 (12)  3 (9.4)  <0.05 
Fetal 
Pre-term Birth  5 (26.3)  2 (8)  3 (9.4)  <0.05 
Results are expressed in number (%), NS not significant, 
†χ
2-test 
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Basal  mass  index  was  highest  in  Group  C  with 
wider range 32.1 (20-40) (p<0.05). Group A had 
higher median fasting glucose level 120 mg/dl in 
diagnostic OGTT while range was wider in group 
B  that  is  62-145  (p<0.05).  Even  though,  second 
and third hours postprandial glucose levels during 
diagnostic  OGTT  were  significantly  different 
among the groups (p<0.05) (Table 1). 
        In the bivariate analysis evaluating the asso-
ciation  between the period  of diagnosis  and  out-
comes (Table 2), the period was found to be asso-
ciated with three out of nine maternal outcomes: 
pregnancy-induced hypertension 5 (26.3%), poly-
hydramnios  5  (26.3%)  and  insulin  treatment  13 
(68.4%) which were higher in women with earlier 
GDM diagnosis (p<0.05). While discussing the fe-
tal outcomes, the period was found to be associated 
with four out of eight factors that is 5-min Apgar 
<7 3(15.8%), large for gestational age 5(26.3%), 
respiratory distress 6(31.5%) and pre-term delivery 
5(26.3%) were more frequent seen in the Group A 
(p<0.05).  No  differences  were  found  in  macro-
somia, perinatal mortality, hypoglycemia and hy-
perbilirubinemia (Table 2). 
DISCUSSION 
In this study, the incidence of GDM was 3.1%, a 
figure very less to the 13.9% found in the Chinese 
population in Australia
18 but consistent with 2-5% 
in the US
19, and little bit high than 2.8%in Bah-
rain
20 and 2.7% in Australia
21. Only a few studies 
in past had explained the relationship between ges-
tational age at GDM diagnosis and maternal and 
neonatal outcome. This relationship was first ana-
lyzed by Berkowitz in 1992
22 followed by Bartha 
in 2000
8 and Svare in 2001
23. On the other hand, 
some  authors  had  mainly  paid  attention  towards 
maternal characteristics with GDM diagnosis early 
in pregnancy, but perinatal outcome was not inves-
tigated
9,24.  The  formerly  mentioned  studies  were 
comparable with our results as early diagnosis was 
related with higher rates of insulin treatment
8,23 and 
higher  or  borderline  increased  hypertension 
rates
8,22. Our study results highlighted that earlier 
diagnosed GDM cases developed not only hyper-
tension and required of insulin treatment but also 
polyhydramnios  was  also  more  frequent  in  the 
same  group  which  is  contrary  to  formerly  men-
tioned studies. On  the  other  hand  overall  insulin 
therapy was initiated in 42.1% subjects higher than 
23.2% used in the study of Moses
25. We did not 
measure post-partum glucose levels or tolerance of 
the subjects as done by Svare
23. In relation to fetal 
outcomes, Overall rate of large for gestational age 
in  present  study  was  11  (14.5%)  lesser  than 
(16.7%) found in the study of Lepord and Worda
26 
while macrosomia rate 8 (10.5%) was higher than 
(8%) seen in Moses study
25. While discussing the 
study of Malinowska, hyperbilirubinemia (17.3%) 
were  seen  infrequently  than  21.1%  of  our  study 
and  repeatedly  seen  the  cases  of  hypoglycemia 
(15.6%) than our study that is 7.9%
27. Berkowitz 
and  Svare
21,22  did not focus the dissimilarities  in 
women diagnosed with GDM early in pregnancy. 
However, Bartha
8 reported an increased rate of hy-
poglycemia  in  these  infants  as  noted  by  us  3 
(15.8%)  and  increased  perinatal  mortality  which 
was not prominent in our study 2(10.5%) in earlier 
diagnosed  group.  In  the  present  paper,  we  also 
found more frequent rate of preterm birth, respira-
tory distress, and 5-min Apgar <7 in earlier diag-
nosed group.  
We concluded that thorough metabolic man-
agement and good on the whole outcome, earlier 
diagnosis of GDM is associated with poor newborn 
outcome. 
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